VDAC1 and Alzheimer disease: Experiments in the HT22 cell line and in the mouse cholinergic septal neuronal cell line SN56 showed that the application of anti-VDAC antibodies protected from Aβ-peptide-mediated neurotoxicity, demonstrating the involvement of plasmalemmal VDAC in AD [108].